Tuesday 27 to Thursday 29 June 2023
A fantastic opportunity to learn at this interactive radiotherapy summer school. The programme includes a wide variety of plenary sessions, workshops, debates across 4 areas of protons, stereotactic ablative radiotherapy (SABR), imaging and adaptive radiotherapy as well as Big Data.
The course is deliberately aimed at a wide audience including radiographers, medical physicists, clinicians and those from a more academic environment who wish to learn more about the subject.
| Time | Session |
|---|---|
| 12:45 | Registration |
| 13:00- 13:45 | Session 1: What have we learnt? Professor Karen Kirkby, Chair in Proton Therapy Physics, University of Manchester |
| 13:00 | All you need to know about the bragg peak but were afraid to ask Mr Matthew Clarke, Consultant clinical scientist, The Christie NHS Foundation Trust |
| 13:45 | Learning from our clinical practice: clinical case examples |
14:45 - break
| Time | Session |
|---|---|
| 15:00-16:00 | Session 2: what are we discovering? |
| 15:00 | What we discovering in clinical trials? Dr Matt Lowe, Principal clinical scientist, The Christie NHS Foundation Trust |
| 15:20 | HPB clinical trials in PBT - the UK perspective Dr Ganesh Radhakrishna, Consultant clinical oncologist, The Christie NHS Foundation Trust |
| 15:40 | What are we discovering in the research room? Dr John Warmenhoven, The University of Manchester Dr Nicholas Henthorn, The University of Manchester |
| 16:00-16:45 | Session 3: Where next? Professor Ran Mckay, Director of Medical Physics and Engineering, The Christie NHS Foundation Trust |
| 16:00 | Proton Therapy in 2025: FLASH vs Proton- Arc vs LET- optimised planning Dr Mike Merchant, Lecturer in Proton Therapy Phsyics, University of Manchester |
16:45 - close of day
| Time | Session |
|---|---|
| 09:00 | Registration and coffee |
| 09:10 | MR-guided RT Prof Peter Hoskin, Professor in Clinical Oncology, University of Manchester |
| 09:30 | Optimising MR for Radiotherapy Michael Dubec, Principal clinical scientist (MRI), The Christie NHS Foundation Trust |
| 09:50 | Clinical applications of functional MR Dr Cynthia Eccles, Consultant research radiographer, Head of radiotherapy developments, The Christie NHS Foundation Trust |
| 10:10 | Integrating MR in to the radiotherapy workflow Linnea Freear, Principal clinical scientist, The Christie NHS Foundation Trust |
| 10:30 | Organs at Risk- do we know what we are talking about? Dr Romaana Mir, Consultant Clinical Oncologist, Mount Vernon Cancer Centre |
10:50 - break
| Time | Session |
|---|---|
| 11:10 | Can radiotherapy be carbon neutral? Dr Rob Chuter, Principal Clinical Scientist, The Christie NHS Foundation Trust |
| 11:30 | Debate: MR Guided RT vs Protons Frank Brewster, Clinical Scientist, The Christie NHS Foundation Trust Dr Cynthia Eccles, Consultant Research Radiographer, The Christie NHS Foundation Trust Claire Neldder, The Christie NHS Foundation Trust |
12:30 - lunch
| Time | Session |
|---|---|
| 13:30 | Chairperson's welcome Julia Handley, The Christie NHS Foundation Trust |
| 13:40 | SABR- what's next? Dr Andrew Brocklehurst, Clinical Oncology SABR Fellow, The Christie NHS Foundation Trust |
| 14:10 | Workshop A: SABR abdominal SABR case based discussion Dr Andrew Brocklehurst, Clinical Oncology SABR Fellow, The Christie NHS Foundation Trust Rachael Hall, Principal Clinical Scientist/SABR Physics Lead, The Christie NHS Foundation Trust |
| 14:10 | Workshop B: SRS- cranial case based discussion Dr Jenny King, Consultant Clinical Oncologist, The Christie NHS Foundation Trust Daniel Welsh, Principal Clinical Scientist, The Christie NHS Foundation Trust Dr Geoff Heyes, Head of Radiotherapy Treatment Planning, University Hospitals Birmingham NHS Foundation Trust |
15:10 - break
| Time | Session |
|---|---|
| 15:30 | Re-irradiation |
| 15:55 | Cardiac SABR Dr Jim Daniel, Head of Treatment Planning, South Tees Hospitals NHS Foundation Trust |
| 16:15 | Cyber knife vs linac for SABR Dr Geoff Heyes, Head of Radiotherapy Treatment Planning, University Hospitals Birmingham NHS Foundation Trust |
| Time | Session |
|---|---|
| 08:45 | Registration and Coffee |
| 09:15 | Chairperson's welcome |
| 09:30 | Casual inference Dr Matthew Sperrin, Senior Lecturer in Health Data Science |
| 10:00 | Autocontouring |
| 10:30 | Modelling Dr Marianne Aznar, Senior Lecturer in Radiotherapy Physics, University of Manchester |
| 11:00 | How to learn from every patient Dr Alan Mcwillliam, Senior Lecturer in Translational Radiotherapy, University of Manchester |
11:30 - break
| Time | Session |
|---|---|
| 11:50 | AI for beginners Dr Eliana Vasquezosirio, Senior Research Fellow, University of Manchester |
| 12:20 | Wearable tech to optimise cancer care Michael Merchant, Lecturer in Proton Therapy Physics, University of Manchester |
| 12:50 | Debate- AI can replace humans in radiotherapy, we just won't let it Dr Kate Haslett, Consultant Clinical Oncologist, The Christie NHS Foundation Trust Prof Marcel van Herk, Chair in Radiotherapy Physics, University of Manchester Matt Lowe, Principal Clinical Scientist, The Christie NHS Foundation Trust |
13:35 - break
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. Elekta openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To them, it's personal, and their global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care.
Elekta don’t just build technology, we build hope.
Elekta is headquartered in Stockholm, Sweden, with offices in more than 120 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on Twitter.
Xiel is a specialist distributor of medical technologies in UK and Ireland. They work with global leading solution providers; therefore, continuously improving efficiency and quality for their customers. Their partners research and develop highly specific products for what is often a small world market. The expertise of Xiel lies in their deep understanding of the structure and organisation of radiotherapy departments in the UK and Ireland, for them to advise on the best solutions possible.
Xiel exclusively represent Sun Nuclear, CIRS, Gammex and MVision to name a few. Please visit the booth today to meet their radiotherapy experts.
Xiel. Exceptional Products. Extraordinary Service. Everyday.
AMG Medtech Ltd are a specialist consultancy service and distributor of cutting edge medical AI technologies and software.
The radiotherapy AI software solutions are vendor neutral, cloud or locally installed for use with all radiotherapy treatment modalities.
The full range of AMG Medtech Ltd's radiotherapy solutions can be viewed on the AMG website.
Sign up to our education events mailing list to be kept up to date with this and future events
© 2023 The Christie NHS Foundation Trust
The Christie Charity